Evan Seigerman
Stock Analyst at BMO Capital
(1.4)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
IRON Disc Medicine | Maintains: Outperform | 112 120 | 51.62 | 132.47% | 6 | May 12, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Market Perform | 96 115 | 125.9 | -8.66% | 15 | May 6, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 115 120 | 106.17 | 13.03% | 16 | Apr 17, 2025 | |
BIIB Biogen | Maintains: Market Perform | 156 139 | 124.65 | 11.51% | 18 | Feb 13, 2025 | |
VRTX Vertex Pharmaceutica... | Maintains: Outperform | 520 545 | 443.7 | 22.83% | 15 | Jan 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 57 61 | 46.97 | 29.87% | 11 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 48 52 | 67.27 | -22.7% | 12 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1001 1101 | 770.08 | 42.97% | 8 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 22.05 | 81.41% | 1 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 110 59 | n/a | n/a | 8 | Dec 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 40 | 9.22 | 333.84% | 1 | Oct 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 757 788 | 511.36 | 54.1% | 15 | Aug 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 8 3 | 2.01 | 24.38% | 2 | Aug 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 263 243 | 272.63 | -10.87% | 6 | Apr 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 4.68 | 156.41% | 2 | Mar 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 60 | 24.04 | 149.58% | 1 | Nov 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 27 | 1.33 | 1930.08% | 2 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 | n/a | n/a | 4 | Mar 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 9 15 | n/a | n/a | 4 | Dec 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 35 | n/a | n/a | 4 | Sep 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 14 17 | n/a | n/a | 6 | Aug 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 30 | 1.31 | 2190.08% | 3 | May 12, 2020 |